ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 7,292 shares, a growth of 58.6% from the July 15th total of 4,599 shares. Approximately 4.3% of the company’s shares are sold short. Based on an average trading volume of 4,832 shares, the short-interest ratio is currently 1.5 days.
ProShares UltraShort Nasdaq Biotechnology Price Performance
Shares of ProShares UltraShort Nasdaq Biotechnology stock opened at $10.53 on Thursday. ProShares UltraShort Nasdaq Biotechnology has a fifty-two week low of $10.51 and a fifty-two week high of $29.18. The business’s fifty day moving average is $13.82 and its two-hundred day moving average is $16.19.
ProShares UltraShort Nasdaq Biotechnology Company Profile
Featured Stories
- Five stocks we like better than ProShares UltraShort Nasdaq Biotechnology
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
